DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹1,261 Cr | ₹2,459 Cr | ₹1,912 Cr | ₹1,947 Cr | ₹1,216 Cr |
What is the latest Cash Flow from Operating Activities ratio of DIVIS LABORATORIES ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹1,261 Cr |
Mar2023 | ₹2,459 Cr |
Mar2022 | ₹1,912 Cr |
Mar2021 | ₹1,947 Cr |
Mar2020 | ₹1,216 Cr |
How is Cash Flow from Operating Activities of DIVIS LABORATORIES Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹1,261 Cr | -48.72 | |
Mar2023 | ₹2,459 Cr | 28.62 | |
Mar2022 | ₹1,912 Cr | -1.80 | |
Mar2021 | ₹1,947 Cr | 60.12 | |
Mar2020 | ₹1,216 Cr | - |
Compare Cash Flow from Operating Activities of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹162,403.7 Cr | 8.8% | 5.1% | 64.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,084.0 Cr | -0% | -4.6% | 18.9% | Stock Analytics | |
CIPLA | ₹118,853.0 Cr | 2.4% | -1.1% | 0.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,143.0 Cr | 2.6% | -9.9% | -0.4% | Stock Analytics | |
MANKIND PHARMA | ₹102,284.0 Cr | -0.1% | -12.4% | 18.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,459.0 Cr | 3.6% | -0.1% | 22.7% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 8.8% |
5.1% |
64.4% |
SENSEX | 0.7% |
-0.1% |
8.8% |
You may also like the below Video Courses